Wolverine Trading
XBI icon

Wolverine Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wolverine Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$36.6M Sell
368,000
-174,300
-32% -$15.7M 0.03% 400
2025
Q2 		$45M Buy
542,300
+263,300
+94% +$21M 0.05% 271
2025
Q1 		$23.5M Sell
279,000
-196,400
-41% -$17.6M 0.03% 359
2024
Q4 		$42.7M Sell
475,400
-58,400
-11% -$5.66M 0.04% 268
2024
Q3 		$52.5M Buy
533,800
+190,800
+56% +$18.7M 0.06% 199
2024
Q2 		$31.8M Sell
343,000
-149,800
-30% -$13.4M 0.03% 287
2024
Q1 		$46.8M Sell
492,800
-96,600
-16% -$8.96M 0.05% 206
2023
Q4 		$52.6M Buy
589,400
+193,100
+49% +$14.3M 0.06% 195
2023
Q3 		$28.9M Buy
+396,300
New +$31.7M 0.03% 269
2023
Q2 		– Sell
-481,500
Closed -$36M – 5067
2023
Q1 		$36M Sell
481,500
-15,200
-3% -$1.26M 0.06% 212
2022
Q4 		$41.2M Sell
496,700
-36,000
-7% -$2.91M 0.06% 228
2022
Q3 		$42M Sell
532,700
-175,100
-25% -$14.8M 0.07% 159
2022
Q2 		$52.9M Sell
707,800
-43,100
-6% -$3.24M 0.09% 112
2022
Q1 		$68.1M Buy
750,900
+159,500
+27% +$14.7M 0.09% 134
2021
Q4 		$67M Buy
591,400
+346,500
+141% +$41.8M 0.08% 165
2021
Q3 		$30.8M Buy
244,900
+1,400
+0.6% +$180K 0.03% 370
2021
Q2 		$33.1M Buy
243,500
+70,600
+41% +$9.28M 0.05% 267
2021
Q1 		$22.5M Sell
172,900
-8,700
-5% -$1.3M 0.03% 361
2020
Q4 		$26.2M Buy
+181,600
New +$23.3M 0.04% 318
2020
Q3 		– Sell
-198,500
Closed -$21.9M – 5269
2020
Q2 		$21.9M Sell
198,500
-8,900
-4% -$877K 0.06% 221
2020
Q1 		$16.2M Sell
207,400
-1,100
-0.5% -$97.4K 0.05% 284
2019
Q4 		$19.8M Buy
+208,500
New +$18M 0.05% 369
2019
Q3 		– Sell
-269,400
Closed -$23.6M – 5128
2019
Q2 		$23.6M Sell
269,400
-13,100
-5% -$1.12M 0.07% 242
2019
Q1 		$25.6M Buy
282,500
+11,200
+4% +$953K 0.07% 201
2018
Q4 		$19M Buy
271,300
+11,100
+4% +$894K 0.05% 270
2018
Q3 		$24.9M Buy
260,200
+69,800
+37% +$6.77M 0.05% 239
2018
Q2 		$16.7M Hold
190,400
– – 0.04% 306
2018
Q1 		$16.7M Buy
190,400
+49,500
+35% +$4.52M 0.04% 306
2017
Q4 		$12M Buy
140,900
+43,200
+44% +$3.62M 0.04% 428
2017
Q3 		$8.46M Sell
97,700
-133,100
-58% -$10.7M 0.03% 491
2017
Q2 		$18.1M Buy
230,800
+47,600
+26% +$3.38M 0.08% 221
2017
Q1 		$12.7M Buy
183,200
+44,900
+32% +$3.02M 0.07% 298
2016
Q4 		$8.19M Sell
138,300
-44,500
-24% -$2.75M 0.04% 467
2016
Q3 		$12M Sell
182,800
-72,100
-28% -$4.46M 0.06% 381
2016
Q2 		$13.8M Buy
+254,900
New +$14M 0.08% 251

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wolverine Trading's XBI Position: Q3 2025 in Review

Wolverine Trading reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 16% in Q3 2025, selling an estimated $1.07M and leaving 61,981 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1232.

Wolverine Trading first reported a position in XBI in Q2 2016 and has held it in 35 quarters since. The position peaked at $18.1M in Q4 2021. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Wolverine Trading held 61,981 shares of State Street SPDR S&P Biotech ETF worth $6.16M as of Q3 2025.
  • Wolverine Trading sold 11,862 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $1.07M.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1232 holding.
  • Wolverine Trading first reported a position in State Street SPDR S&P Biotech ETF in Q2 2016 and has held it in 35 quarters since.
  • Wolverine Trading's State Street SPDR S&P Biotech ETF position peaked at $18.1M in Q4 2021.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.